Results 141 to 146 of about 4,861,637 (146)

Local control strategies for management of NSCLC with oligoprogressive disease

Cancer Treatment Reviews, 2023
exaly  

Detection of oligoprogressive disease in oncogene-addicted non-small cell lung cancer using PET/CT versus CT in patients receiving a tyrosine kinase inhibitor

Lung Cancer, 2018
Terry Ng, Derek E Smith, Rustain Morgan
exaly  

Tumour-Specific Growth Rate as a Potential Predictor of Outcomes in Oligoprogressive Disease Treated With Stereotactic Body Radiotherapy

Clinical Oncology
Andrew Hope, Inmaculada Navarro-Domenech, P Lindsay   +2 more
exaly  

Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer

Radiotherapy and Oncology
Emma Doyle
exaly  

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

Lancet, The
Afsheen Iqbal, Rachel Sanford, Jeeban P Das   +2 more
exaly  

The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial

International Journal of Radiation Oncology Biology Physics
Rachel M Glicksman, Ciara O'Brien
exaly